Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: Implications for routine resistance screening before initiation of antiretroviral therapy
Richard M. Novak, Li Chen, Rodger David MacArthur, John D. Baxter, Kathy Huppler Hullsiek, Grace Peng, Ying Xiang, Christopher Henely, Barry Schmetter, Jonathan Uy, Mary Van Den Berg-Wolf, Michael Kozal
Fingerprint
Dive into the research topics of 'Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: Implications for routine resistance screening before initiation of antiretroviral therapy'. Together they form a unique fingerprint.